{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:33:44Z","timestamp":1793313224669,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.euroneuro.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T04:52:17Z","timestamp":1379566337000},"page":"1754-1762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS\u00ae) in the Swedish COAST-study"],"prefix":"10.1016","volume":"23","author":[{"given":"Cecilia","family":"Brain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Allerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sameby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Joas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Karilampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margda","family":"Waern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1176\/ajp.150.6.873","article-title":"Assessment of insight in psychosis","volume":"150","author":"Amador","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-1781(88)90076-5","article-title":"The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families","volume":"26","author":"Cornblatt","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archpsyc.62.7.717","article-title":"Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals","volume":"62","author":"Day","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/11634500-000000000-00000","article-title":"Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis","volume":"26","author":"De Hert","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4088\/JCP.v65n0311","article-title":"Adherence to conventional and atypical antipsychotics after hospital discharge","volume":"65","author":"Diaz","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1176\/appi.ajp.159.1.103","article-title":"Antipsychotic medication adherence: is there a difference between typical and atypical agents?","volume":"159","author":"Dolder","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.euroneuro.2010.02.001","article-title":"Drug attitude as predictor for effectiveness in first-episode schizophrenia: results of an open randomized trial (EUFEST)","volume":"20","author":"Gaebel","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1997.01830140071013","article-title":"Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia","volume":"54","author":"Gold","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib11","year":"1976"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib12","series-title":"Wisconsin Card Sorting Test manual: Revised and Expanded","author":"Heaton","year":"1993"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib15","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-9964(02)00314-6","article-title":"Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia","volume":"63","author":"Jeste","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0447.2012.01911.x","article-title":"Predictors of medication adherence in patients with schizophrenia and bipolar disorder","volume":"127","author":"Jonsdottir","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/NMD.0b013e318221413e","article-title":"Cognition and global assessment of functioning in male and female outpatients with schizophrenia spectrum disorders","volume":"199","author":"Karilampi","year":"2011","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mpr.335","article-title":"The predictive validity of subjective adherence measures in patients with schizophrenia","volume":"20","author":"Kikkert","year":"2011","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1751-7893.2010.00174.x","article-title":"Is there an association between neurocognitive performance and medication adherence in first episode psychosis?","volume":"4","author":"Lepage","year":"2010","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/schbul\/sbm002","article-title":"Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review","volume":"33","author":"Lincoln","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/08039488.2011.577186","article-title":"Suicides during 7 years among a catchment area cohort of patients with psychoses","volume":"66","author":"Lindstrom","year":"2012","journal-title":"Nord. J. Psychiatry"},{"issue":"Suppl. 44","key":"10.1016\/j.euroneuro.2013.09.001_bib27","first-page":"5","article-title":"Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)","volume":"55","author":"Lindstrom","year":"2001","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/ps.2006.57.8.1203","article-title":"Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia","volume":"57","author":"Maeda","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1176\/appi.ps.54.5.719","article-title":"Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program","volume":"54","author":"Menzin","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.comppsych.2012.12.014","article-title":"Insight in stable schizophrenia: relations with psychopathology and cognition","volume":"54","author":"Mingrone","year":"2013","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psychres.2007.05.001","article-title":"Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity","volume":"157","author":"Nakonezny","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.euroneuro.2012.02.008","article-title":"DAI-10 is as good as DAI-30 in schizophrenia","volume":"22","author":"Nielsen","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1017\/S0033291703008328","article-title":"How often do patients with psychosis fail to adhere to treatment programmes? A systematic review","volume":"33","author":"Nose","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/JCP.v69n0114","article-title":"Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study","volume":"69","author":"Perkins","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trailmaking Test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2006.11.015","article-title":"The use of electronic monitoring (MEMS\u00ae) to evaluate antipsychotic compliance in outpatients with schizophrenia","volume":"90","author":"Remington","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib38","series-title":"L'examen clinique en psychologie","author":"Rey","year":"1964"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4088\/JCP.v61n0511","article-title":"Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol","volume":"61","author":"Rosenheck","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ps.48.1.82","article-title":"Psychiatric patients' attitudes about medication and factors affecting noncompliance","volume":"48","author":"Ruscher","year":"1997","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1185\/030079907X226050","article-title":"Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States","volume":"23","author":"Sun","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"American. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.npp.1301347","article-title":"Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study","volume":"32","author":"van Haren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/schbul\/sbj075","article-title":"Defining and assessing adherence to oral antipsychotics: a review of the literature","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophrenia. Bull."},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2013.09.001_bib48","first-page":"1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib45","series-title":"Wechsler Adult Intelligence Scale \u2013 Revised","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.euroneuro.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2011.11.008","article-title":"Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia","volume":"134","author":"Yang","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1176\/appi.ajp.159.10.1653","article-title":"Interventions to improve medication adherence in schizophrenia","volume":"159","author":"Zygmunt","year":"2002","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13002587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13002587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T11:52:37Z","timestamp":1646567557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13002587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924977X13002587"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.09.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS\u00ae) in the Swedish COAST-study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}